Dr. Katja Scharpwinkel - Net Worth and Insider Trading
Dr. Katja Scharpwinkel Net Worth
The estimated net worth of Dr. Katja Scharpwinkel is at least $0 dollars as of 2024-11-08. Dr. Katja Scharpwinkel is the Board of Directors of Basf SE and owns about 0 shares of Basf SE (XTER:BAS) stock worth over $0. Details can be seen in Dr. Katja Scharpwinkel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dr. Katja Scharpwinkel has not made any transactions after 2024-05-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dr. Katja Scharpwinkel
Dr. Katja Scharpwinkel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dr. Katja Scharpwinkel owns 1 companies in total, including Basf SE (XTER:BAS) .
Click here to see the complete history of Dr. Katja Scharpwinkel’s form 4 insider trades.
Dr. Katja Scharpwinkel Latest Holdings Summary
Dr. Katja Scharpwinkel currently owns a total of 1 stock. Dr. Katja Scharpwinkel owns 0 shares of Basf SE (XTER:BAS) as of May 27, 2024, with a value of $0.
Dr. Katja Scharpwinkel Form 4 Trading Tracker
According to the SEC Form 4 filings, Dr. Katja Scharpwinkel has made a total of 1 transactions in Basf SE (XTER:BAS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Basf SE is the acquisition of 2,000 shares on May 27, 2024, which cost Dr. Katja Scharpwinkel around $97,050.
Insider Trading History of Dr. Katja Scharpwinkel
- 1
Dr. Katja Scharpwinkel Trading Performance
GuruFocus tracks the stock performance after each of Dr. Katja Scharpwinkel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dr. Katja Scharpwinkel is -7.3%. GuruFocus also compares Dr. Katja Scharpwinkel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dr. Katja Scharpwinkel within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dr. Katja Scharpwinkel's insider trading performs compared to the benchmark.
Performance of Dr. Katja Scharpwinkel
Dr. Katja Scharpwinkel Ownership Network
Ownership Network List of Dr. Katja Scharpwinkel
Ownership Network Relation of Dr. Katja Scharpwinkel
Dr. Katja Scharpwinkel Owned Company Details
What does Basf SE do?
Who are the key executives at Basf SE?
Dr. Katja Scharpwinkel is the Board of Directors of Basf SE. Other key executives at Basf SE include Board of Directors Dr. Dirk Elvermann , Supervisory Board Dr. Kurt Bock , and Supervisory Board Prof. Dr. Stefan Asenkerschbaumer .
Basf SE (XTER:BAS) Insider Trades Summary
Over the past 18 months, Dr. Katja Scharpwinkel made 1 insider transaction in Basf SE (XTER:BAS) with a net purchase of 2,000. Other recent insider transactions involving Basf SE (XTER:BAS) include a net purchase of 9,350 shares made by Dr. Dirk Elvermann , a net purchase of 11,200 shares made by Dr. Stephan Kothrade , and a net purchase of 21,277 shares made by Dr. Markus Kamieth .
In summary, during the past 3 months, insiders sold 0 shares of Basf SE (XTER:BAS) in total and bought 1,300 shares, with a net purchase of 1,300 shares. During the past 18 months, 0 shares of Basf SE (XTER:BAS) were sold and 51,710 shares were bought by its insiders, resulting in a net purchase of 51,710 shares.
Basf SE (XTER:BAS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Basf SE Insider Transactions
Dr. Katja Scharpwinkel Mailing Address
Above is the net worth, insider trading, and ownership report for Dr. Katja Scharpwinkel. Currently GuruFocus does not have mailing address information for Dr. Katja Scharpwinkel.